MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
批准号:
10001079
负责人:
DAVID B CORRY
金额:
$40.15万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31
关键词:
AccountingAir PollutionAnti-Inflammatory AgentsApoptosisAutoimmune ProcessCD4 Positive T LymphocytesCD86 geneCarbon BlackCell Differentiation processCellsChronic Obstructive Airway DiseaseDendritic CellsDevelopmentDown-RegulationEquilibriumExerciseFOXO1A geneFamilyGene ExpressionGenesGoalsHistone DeacetylaseHomeostasisHumanHypercapniaIL6 geneImmuneImmune responseInflammationInflammatoryInhalationInnate Immune ResponseInterleukin-10Knock-outKnockout MiceLeadLoxP-flanked alleleLungLung InflammationMediatingMediator of activation proteinMessenger RNAMethodsMicroRNAsModelingMolecularMolecular AnalysisMorbidity - disease rateMusMyelogenousPathologicPhenotypePulmonary EmphysemaRoleSeveritiesSmokeSmokerStressT-LymphocyteTestingTherapeuticTobaccoTransgenic MiceUp-RegulationWild Type MouseWorkautoreactivitybasecigarette smokecytokinegenome-wideglobal healthmacrophagemembermortalitymouse modelnanosizednovel therapeutic interventionoverexpressionparticleresponsetooltranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chronic obstructive pulmonary disease (COPD) is a major rising global health threat in the 21st century.
Emphysema, a progressive and destructive autoimmune endotype of COPD that often presents with
hypercapnia and exercise limitation, is associated with significant morbidity and mortality. Like the well-
established noxious effects of cigarette smoke (CS), we have demonstrated that nano-sized carbon black
(nCB) particles, generated by incomplete combustion of tobacco, can cause emphysema. The mechanism for
nCB or CS-mediated emphysema development includes activation of lung myeloid dendritic cells (mDCs) that
promote differentiation of autoreactive T helper 1 (TH1), TH17 cells and reduced inducible regulatory T (iTreg)
cells in the lungs. We have found that let-7 miRNAs are the dominant miRNAs expressed in mouse and human
lung and immune cells. This and other preliminary findings suggest that let-7 members critically determine (i.e.,
“threshold”) distinct subsets of target genes depending on their aggregate expression levels. Our central
hypothesis states that in response to CS, let-7 loci cooperate to modulate emphysema and orchestrate
activation of mDCs and TH17 cells by thresholding target gene expression. We will test our hypothesis through
the following Specific Aims: 1. Elucidate the intrinsic requirement of the let-7bc and let-7afd clusters in
activation of acquired immune responses in experimental emphysema. Hypothesis: The let-7bc and let-7afd
clusters work in tandem to generate thresholds in target gene expression in CD4+ T cells and orchestrate
homeostatic TH17/iTreg balance, lung inflammation, and emphysema. We will perform comprehensive
histopathological and cellular studies of let-7bc- and let-7afd-deficient mice to determine the let-7 mechanism
of action after nCB or CS treatment. We will further identify target genes that potentially suppress (IL10, Foxo1)
or enhance (Stat3, and RORγt) inflammation and emphysema expression. 2. Determine the role of let-7afd
cluster on innate immune responses in emphysema. Hypothesis: Let-7 serves to temper molecular
programming of TH17 driven emphysema acting in part in mDCs. Histopathological and molecular analysis of
conditional (let-7 floxed mice) and global cluster knockouts, and let-7 transgenic mice will allow us to
interrogate the mechanism(s) by which let-7 modulates TH17/iTreg homeostasis, apoptosis, and proliferation.
3. Determine the role of Let-7afd cluster in human emphysema. Hypothesis: Coordinate downregulation of Let-
7afd cluster in emphysematous lung mDCs promotes TH17 inflammation and upregulation of pro-inflammatory
and co-stimulatory target genes. We will discern the pathophysiological consequence of reduced Let-7afd
expression and overall Let-7 activity in the control of human lung mDC-mediated activation (e.g., induction of
CD86, IL6) that is necessary for TH17 cell differentiation. We will also examine the role of Let-7afd
overexpression using emphysematous human mDCs as a pilot strategy to inhibit TH17 inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular and Cellular Dissection of miRNAs in Controlling Allergic Airway Inflammation in Mice
-
批准号:10477187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
Molecular and Cellular Dissection of miRNAs in Controlling Allergic Airway Inflammation in Mice
-
批准号:10664926
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
IMPACC-MEDVAMC
-
批准号:10202368
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
Molecular and Cellular Dissection of miRNAs in Controlling Allergic Airway Inflammation in Mice
-
批准号:10012111
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
IMPACC-MEDVAMC
-
批准号:10265764
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2020
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:10240489
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:10470262
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
Pathogenesis of Polymicrobial Cerebritis-Related Dementia
-
批准号:10119639
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
FUNGAL PATHOGENESIS OF MODERATE TO SEVERE ASTHMA
-
批准号:10357580
-
项目类别:
-
资助金额:$50.52万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
MECHANISM AND FUNCTION OF LET-7, A NOVEL MODULATOR OF TH17-DEPENDENT EMPHYSEMA
-
批准号:9766362
-
项目类别:
-
资助金额:$40.15万
-
财政年份:2018
-
负责人:DAVID B CORRY
-
依托单位:
STAT Inhibitors for Asthma Therapy
-
批准号:9202192
-
项目类别:
-
资助金额:$22.75万
-
财政年份:2016
-
负责人:DAVID B CORRY
-
依托单位:
Th1 and Th17 Mediators in Experimental Emphysema
-
批准号:9085352
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Th1 and Th17 Mediators in Experimental Emphysema
-
批准号:8510061
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Th1 and Th17 Mediators in Experimental Emphysema
-
批准号:8701133
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Carbon Black Induced Activation of Lung APCs
-
批准号:8542423
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Carbon Black Induced Activation of Lung APCs
-
批准号:8670556
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:DAVID B CORRY
-
依托单位:
Molecular Phenotypes for Lung Diseases
-
批准号:7691799
-
项目类别:
-
资助金额:$69.25万
-
财政年份:2008
-
负责人:DAVID B CORRY
-
依托单位:
Molecular Phenotypes for Lung Diseases
-
批准号:7902047
-
项目类别:
-
资助金额:$69.22万
-
财政年份:2008
-
负责人:DAVID B CORRY
-
依托单位:
Molecular Phenotypes for Lung Diseases
-
批准号:8112589
-
项目类别:
-
资助金额:$68.73万
-
财政年份:2008
-
负责人:DAVID B CORRY
-
依托单位:
Environmental Proteinases in Human/Experimental Asthma
-
批准号:7150845
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2006
-
负责人:DAVID B CORRY
-
依托单位:
海外基金